Aurobindo Pharma surges on getting USFDA’s nod for Cefixime for Oral Suspension

16 Apr 2015 Evaluate

Aurobindo Pharma is currently trading at Rs. 1377.10, up by 16.10 points or 1.18% from its previous closing of Rs. 1361.00 on the BSE.

The scrip opened at Rs. 1366.20 and has touched a high and low of Rs. 1393.80 and Rs. 1366.20 respectively. So far 100259 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 1 has touched a 52 week high of Rs. 1393.80 on 16-Apr-2015 and a 52 week low of Rs. 528.00 on 17-Apr-2014.

Last one week high and low of the scrip stood at Rs. 1393.80 and Rs. 1302.00 respectively. The current market cap of the company is Rs. 40059.97 crore.

The promoters holding in the company stood at 53.97% while Institutions and Non-Institutions held 35.82% and 10.21% respectively.

Aurobindo Pharma has received final approvals from the US Food & Drug Administration (USFDA) to manufacture and market Cefixime for Oral Suspension USP, 100mg/5mL and 200mg/5mL (ANDA 204835). The product is ready for launch. The approved ANDAs are bioequivalent and therapeutically equivalent to the reference listed drug product (RLD) Suprax Oral Suspension USP 100mg/5mL and 200mg/5mL respectively of Lupin Pharmaceuticals Inc.

Cefixime for Oral Suspension is indicated for the treatment of adults and pediatric patients six months of age or older, with infections caused by susceptible strains of the designated organisms in urinary tract infections, otitis media, acute exacerbations of chronic bronchitis, uncomplicated gonorrhea (cervical/urethral), pharyngitis and tonsillitis.

The product has an estimated market size of $123 Million for the twelve months ending February 2015. The company now has 11 ANDAs (represented by 7 product classes) approved out of Unit VI formulation facility in Hyderabad, India for manufacturing Oral Cephalosporin products.

Aurobindo Pharma manufactures generic pharmaceuticals and active pharmaceutical ingredients. The company’s robust product portfolio is spread over 6 major therapeutic/product areas encompassing Antibiotics, Anti-Retrovirals, CVS, CNS, Gastroenterologicals, and Anti-Allergics, supported by an outstanding R&D set-up.

Aurobindo Pharma Share Price

1217.45 -6.20 (-0.51%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×